SecBot SecBot
DEFA14A ·Filed Apr 20, 2026

NVCR

NovoCure Ltd
NEUTRAL
Impact 3/10
Horizonweeks Processed7mo ago SEC0001645113-26-000034
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine annual proxy filing. Monitor for any unexpected outcomes in the shareholder vote, though none are anticipated given the lack of dissident activity. The recent executive compensation change noted in the 8-K is the only notable event.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$12.23
T+0 close · Apr 20, 2026 · via day close
Latest settled
+34.26%
T+60 · $16.42
Vs SPY
+27.36%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 21 $12.23entry
  2. T+1 · 7mo ago +6.46%α +5.44% · $13.02
  3. T+5 · 7mo ago −0.90%α −1.98% · $12.12
  4. T+20 · 6mo ago +42.76%α +37.85% · $17.46
  5. T+60 · 4mo ago +34.26%α +27.36% · $16.42
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

NovoCure's DEFA14A filing is a definitive proxy statement for its 2026 Annual Meeting, where shareholders will vote on director elections, auditor ratification, executive compensation, and an amended incentive plan. This follows recent board changes, suggesting the vote is routine. The filing is neutral with low impact.

Key Financial Metrics

Vote
director election
Meeting
2026-06-03

Key Facts

  • Filing is a definitive proxy statement (DEFA14A) for the 2026 Annual Meeting.
  • Shareholders will vote on 11 director nominees, auditor ratification, executive compensation, and an amended incentive plan.
  • Recent 8-K filing (11 days prior) reported a compensation change for an executive officer.
  • No activist campaign or dissident slate is present; this is a management solicitation.

Financial Impact

No direct financial impact from the proxy filing itself.

executive compensationgovernance

Risk Factors

  • Low risk of shareholder revolt on any proposal, as is typical for routine management solicitations.
  • Potential for minor governance concerns if any director nominee faces significant opposition, though none is indicated.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001645113-26-000034
Document: 0001645113-26-000034-index-headers.html0001645113-26-000034
Document: 0001645113-26-000034-index.html0001645113-26-000034
Document: 0001645113-26-000034.txt0001645113-26-000034

Track record

20 reports on NVCR

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +19.75% at T+20 after the Feb 27, 2026 report. 5 of 7 went positive at some point.

Filters
  1. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $11.83 to $11.30 Now $11.30 −4.48% ▼ −4.48% −2.57% vs SPY
  2. Nov 9, 20267d ago SC 13G/A Neutral 3/10 Entry $11.81 to $11.99 Now $11.30 −4.32% ▲ +1.52% +0.21% vs SPY
  3. Nov 9, 20267d ago 144 Neutral 2/10 Entry $11.81 to $11.99 Now $11.30 −4.32% ▲ +1.52% +0.21% vs SPY
  4. Nov 9, 20267d ago 8-K Bearish 6/10 Entry $12.53 to $11.81 Now $11.30 +9.82% ▲ +5.75% +5.38% vs SPY
  5. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $13.11 to $13.15 Now $11.30 −13.81% ▲ +0.31% +2.08% vs SPY
  6. Oct 1, 20266w ago 8-K Bullish 6/10 Entry $15.92 to $14.94 Now $11.30 −29.02% ▼ −6.16% −6.90% vs SPY
  7. Sep 9, 20269w ago 8-K Neutral 2/10 Entry $15.63 to $15.35 Now $11.30 −27.70% ▼ −1.79% −1.19% vs SPY
  8. Sep 1, 202610w ago 8-K Neutral 3/10 Entry $17.38 to $17.83 Now $11.30 −34.98% ▲ +2.59% +2.15% vs SPY
  9. Jul 23, 202616w ago 8-K Bullish 7/10 Entry $19.99 to $17.65 Now $11.30 −43.47% ▼ −11.71% −11.81% vs SPY
  10. Jun 30, 202619w ago 8-K Bullish 7/10 Entry $15.15 to $15.78 Now $11.30 −25.41% ▲ +4.16% +4.29% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens Wed (10h 44m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 20, 2026